These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Current status of platelet transfusion therapy. Katz AJ; Silver H Conn Med; 1979 Apr; 43(4):195-7. PubMed ID: 436413 [No Abstract] [Full Text] [Related]
7. [Effect of preparation and preservation modality on thrombocyte quality]. Mohren M; Müller H; Körner K; Wiesneth M; Kubanek B; Heimpel H; Seifried E Beitr Infusionsther; 1993; 31():107-10. PubMed ID: 7693237 [TBL] [Abstract][Full Text] [Related]
8. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets. Levy L; Woodfield DG N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558 [TBL] [Abstract][Full Text] [Related]
9. Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation. Gao DY; Neff K; Xiao HY; Matsubayashi H; Cui XD; Bonderman P; Bonderman D; Harvey K; McIntyre JA; Critser J; Miraglia CC; Reid T Cryobiology; 1999 May; 38(3):225-35. PubMed ID: 10328912 [TBL] [Abstract][Full Text] [Related]
10. Quality assessment of platelets stored in a modified platelet additive solution with trehalose at low temperature (10 °C) and in vivo effects on rabbit model of thrombocytopenia. Wang X; Fan Y; Shi R; Li J; Zhao S Platelets; 2015; 26(1):72-9. PubMed ID: 24499059 [TBL] [Abstract][Full Text] [Related]
12. [Alternatives to platelet transfusion]. Mazzara R; Escolar G; Castillo R; Ordinas A Sangre (Barc); 1998 Aug; 43(4):331-8. PubMed ID: 9790001 [No Abstract] [Full Text] [Related]
13. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study. Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979 [TBL] [Abstract][Full Text] [Related]
14. The hemostatic efficacy of platelet components prepared with pathogen inactivation. Corash L Transfusion; 2011 Jun; 51(6):1355-6; author reply 1356-7. PubMed ID: 21658040 [No Abstract] [Full Text] [Related]
15. Summary of a workshop on in vivo efficacy of transfused platelet components and platelet substitutes. Vostal JG; Reid TJ; Mondoro TH Transfusion; 2000 Jun; 40(6):742-50. PubMed ID: 10864998 [No Abstract] [Full Text] [Related]
16. Potential and current development of platelet products. Rivera J; Vicente V Haematologica; 1999 Jun; 84 Suppl EHA-4():115-9. PubMed ID: 10907487 [No Abstract] [Full Text] [Related]
17. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness]. Basire A; Picard C Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423 [TBL] [Abstract][Full Text] [Related]
18. Platelet cryopreservation using a reduced dimethyl sulfoxide concentration and second-messenger effectors as cryopreserving solution. Lozano ML; Rivera J; Corral J; Gonzalez-Conejero R; Vicente V Cryobiology; 1999 Aug; 39(1):1-12. PubMed ID: 10458897 [TBL] [Abstract][Full Text] [Related]
19. Circulation and hemostatic effectiveness of platelets stored at 4 C or 22 C: studies in aspirin-treated normal volunteers. Valeri CR Transfusion; 1976; 16(1):20-3. PubMed ID: 1251454 [No Abstract] [Full Text] [Related]
20. The Lipid Composition of Platelets and the Impact of Storage: An Overview. Green SM; Padula MP; Marks DC; Johnson L Transfus Med Rev; 2020 Apr; 34(2):108-116. PubMed ID: 31987597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]